These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 10371336)

  • 1. No evidence for germline PTEN mutations in families with breast and brain tumours.
    Laugé A; Lefebvre C; Laurent-Puig P; Caux V; Gad S; Eng C; Longy M; Stoppa-Lyonnet D
    Int J Cancer; 1999 Jun; 84(3):216-9. PubMed ID: 10371336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Germline mutations in the PTEN gene in Israeli patients with Bannayan-Riley-Ruvalcaba syndrome and women with familial breast cancer.
    Figer A; Kaplan A; Frydman M; Lev D; Paswell J; Papa MZ; Goldman B; Friedman E
    Clin Genet; 2002 Oct; 62(4):298-302. PubMed ID: 12372056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Germline PTEN mutations in Cowden syndrome-like families.
    Marsh DJ; Dahia PL; Caron S; Kum JB; Frayling IM; Tomlinson IP; Hughes KS; Eeles RA; Hodgson SV; Murday VA; Houlston R; Eng C
    J Med Genet; 1998 Nov; 35(11):881-5. PubMed ID: 9832031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutation spectrum and genotype-phenotype analyses in Cowden disease and Bannayan-Zonana syndrome, two hamartoma syndromes with germline PTEN mutation.
    Marsh DJ; Coulon V; Lunetta KL; Rocca-Serra P; Dahia PL; Zheng Z; Liaw D; Caron S; Duboué B; Lin AY; Richardson AL; Bonnetblanc JM; Bressieux JM; Cabarrot-Moreau A; Chompret A; Demange L; Eeles RA; Yahanda AM; Fearon ER; Fricker JP; Gorlin RJ; Hodgson SV; Huson S; Lacombe D; Eng C
    Hum Mol Genet; 1998 Mar; 7(3):507-15. PubMed ID: 9467011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Male breast cancer in Cowden syndrome patients with germline PTEN mutations.
    Fackenthal JD; Marsh DJ; Richardson AL; Cummings SA; Eng C; Robinson BG; Olopade OI
    J Med Genet; 2001 Mar; 38(3):159-64. PubMed ID: 11238682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel germline mutations in the PTEN tumour suppressor gene found in women with multiple cancers.
    De Vivo I; Gertig DM; Nagase S; Hankinson SE; O'Brien R; Speizer FE; Parsons R; Hunter DJ
    J Med Genet; 2000 May; 37(5):336-41. PubMed ID: 10807691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutation analysis of the putative tumor suppressor gene PTEN/MMAC1 in primary breast carcinomas.
    Rhei E; Kang L; Bogomolniy F; Federici MG; Borgen PI; Boyd J
    Cancer Res; 1997 Sep; 57(17):3657-9. PubMed ID: 9288766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Germline mutations in PTEN are an infrequent cause of genetic predisposition to breast cancer.
    FitzGerald MG; Marsh DJ; Wahrer D; Bell D; Caron S; Shannon KE; Ishioka C; Isselbacher KJ; Garber JE; Eng C; Haber DA
    Oncogene; 1998 Aug; 17(6):727-31. PubMed ID: 9715274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome.
    Liaw D; Marsh DJ; Li J; Dahia PL; Wang SI; Zheng Z; Bose S; Call KM; Tsou HC; Peacocke M; Eng C; Parsons R
    Nat Genet; 1997 May; 16(1):64-7. PubMed ID: 9140396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PTEN mutations in eight Spanish families and one Brazilian family with Cowden syndrome.
    Bussaglia E; Pujol RM; Gil MJ; Martí RM; Tuneu A; Febrer MI; Garcia-Patos V; Ruiz EM; Barnadas M; Alegre M; Serrano S; Matias-Guiu X
    J Invest Dermatol; 2002 Apr; 118(4):639-44. PubMed ID: 11918710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absence of PTEN germ-line mutations in men with a potential inherited predisposition to prostate cancer.
    Cooney KA; Tsou HC; Petty EM; Miesfeldt S; Ping XL; Gruener AC; Peacocke M
    Clin Cancer Res; 1999 Jun; 5(6):1387-91. PubMed ID: 10389923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microsatellite instability, PTEN and p53 germline mutations in glioma families.
    Malmer B; Grönberg H; Andersson U; Jonsson BA; Henriksson R
    Acta Oncol; 2001; 40(5):633-7. PubMed ID: 11669337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breast cancer risk and clinical implications for germline PTEN mutation carriers.
    Ngeow J; Sesock K; Eng C
    Breast Cancer Res Treat; 2017 Aug; 165(1):1-8. PubMed ID: 26700035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymorphisms in PTEN in breast cancer families.
    Carroll BT; Couch FJ; Rebbeck TR; Weber BL
    J Med Genet; 1999 Feb; 36(2):94-6. PubMed ID: 10051004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of PTEN gene mutations in Korean patients with Cowden syndrome and polyposis syndrome.
    Kim DK; Myung SJ; Yang SK; Hong SS; Kim KJ; Byeon JS; Lee GH; Kim JH; Min YI; Lee SM; Jeong JY; Song K; Jung SA
    Dis Colon Rectum; 2005 Sep; 48(9):1714-22. PubMed ID: 16007494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exclusion of a major role for the PTEN tumour-suppressor gene in breast carcinomas.
    Freihoff D; Kempe A; Beste B; Wappenschmidt B; Kreyer E; Hayashi Y; Meindl A; Krebs D; Wiestler OD; von Deimling A; Schmutzler RK
    Br J Cancer; 1999 Feb; 79(5-6):754-8. PubMed ID: 10070865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A heterozygous germline mutation of the PTEN/MMAC1 gene in a patient with Cowden disease.
    Iida S; Nakamura Y; Fujii H; Kimura M; Moriwaki K
    Int J Mol Med; 1998 Mar; 1(3):565-8. PubMed ID: 9852263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel germline mutation of PTEN associated with brain tumours of multiple lineages.
    Staal FJ; van der Luijt RB; Baert MR; van Drunen J; van Bakel H; Peters E; de Valk I; van Amstel HK; Taphoorn MJ; Jansen GH; van Veelen CW; Burgering B; Staal GE
    Br J Cancer; 2002 May; 86(10):1586-91. PubMed ID: 12085208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PTEN mutation spectrum and genotype-phenotype correlations in Bannayan-Riley-Ruvalcaba syndrome suggest a single entity with Cowden syndrome.
    Marsh DJ; Kum JB; Lunetta KL; Bennett MJ; Gorlin RJ; Ahmed SF; Bodurtha J; Crowe C; Curtis MA; Dasouki M; Dunn T; Feit H; Geraghty MT; Graham JM; Hodgson SV; Hunter A; Korf BR; Manchester D; Miesfeldt S; Murday VA; Nathanson KL; Parisi M; Pober B; Romano C; Eng C
    Hum Mol Genet; 1999 Aug; 8(8):1461-72. PubMed ID: 10400993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Germline mutations of p53 but not p16/CDKN2 or PTEN/MMAC1 tumor suppressor genes predispose to gliomas. The ANOCEF Group. Association des NeuroOncologues d'Expression Française.
    Zhou XP; Sanson M; Hoang-Xuan K; Robin E; Taillandier L; He J; Mokhtari K; Cornu P; Delattre JY; Thomas G; Hamelin R
    Ann Neurol; 1999 Dec; 46(6):913-6. PubMed ID: 10589545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.